CARDIOVASCULAR COLLAPSE FROM LOW DOSE BUPIVACAINE
Main Article Content
Keywords
bupivacaine, adverse reactions, local anesthetic agents, toxicity, shock, propofol
Abstract
Bupivacaine is a long-acting local anesthetic agent that is very widely used for cutaneous infiltration, peripheral nerve blocks, epidural anesthesia, and spinal anesthesia. Well-described cardiotoxic effects of bupivacaine and other members of its class include dysrhythmias, hypotension, and depression of cardiac output. The minimum IV dose of bupivacaine previously associated with significant toxicity in humans is 1.6 mg/kg. A case is reported of bradyasystolic arrest with post resuscitation shock, without significant central nervous system (CNS) toxicity, following the injection of less than 1.1 mg/kg bupivacaine in an adult.
References
2. Brown DL, Ransom DM, Hall JA, Leicht CH, Schroeder DR, Offord KP. Regional anesthesia and local anesthetic-induced systemic toxicity:seizure frequency and accompanying cardiovascular changes. Anesth. Analg. 1995, 81 (2), 321-328.
3. Morishima HO, Pedersen H, Finster M, Hiraoka H, Tsuji A, Feldman HS, Arthur GR, Covino BG. Bupivacaine toxicity in pregnant and nonpregnant ewes. Anesthesiology. 1985, 63 (2), 134-139.
4. Reiz S, Nath S. Cardiotoxicity of local anesthetic agents. Br. J. Anaesth. 1986, 58 (7), 736-746.
5. Durrani Z, Winnie AP. Brainstem toxicity with reversible locked-in syndrome after intrascalene brachial plexus block. Anesth Analg. 1991, 72 (2)
249-252.
6. Carpenter RL, Mackey DC. Local Anesthetics. In Clinical Anesthesia, 3rd Ed.; Barash PG, Cullen BF, Stoelting RK. Eds.; Lippincott-Raven: Philadelphia, 1997; 413-440.
7. Apfelbaum JD, Caravati EM, Kerns WP, Bossart PJ, Larsen G. Cardiovascular effects of carbamazepine toxicity. Ann Emerg Med. 1995, 25 (5), 631-635.
8. Mokhlesi B, Leikin JB, Murray P, Corbridge TC.Adult Toxicology in Critical Care, Part II: Specific Poisonings. Chest. 2003, 123 (3), 897-922.
9. Clarkson C, Hondeghem LM. Mechanism for bupivicaine depression of cardiac conduction: Fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 1985;62:396-405.
10. Sztark F, Malgat M, Dabadie P, et. al. Comparison of the effects of bupivicaine and ropivicaine on heart cell mitochondrial bioenergetics. Anesthesiology 1998;88:1340-1349.
11. Reves JG, Glass PSA, Lubarsky DA.Nonbarbiturate Intravenous Anesthetics – Propofol. In Anesthesia, 5th Ed.; Miller, R.D., Ed.; Churchill Livingstone: Philadelphia, 2000; 249-256.
12. Ohmura S, Ohta T, Yamamoto K, Kobayashi T. A comparison of the effects of propofol and sevoflurane on the systemic toxicity of intravenous bupivacaine in rats. Anesth. Analg. 1999, 88 (1) 155-159.
13. Kumar A, Parillo JE. Shock: Classification, Pathophysiology, and Approach to Management. In Critical Care Medicine: Principals of Diagnosis and Management in the Adult, 2nd Ed. Parillo JE; Dellinger RP, Eds.; Mosby: St. Louis, 2002; 371-420.
14. Pickering AE, Hidefumi W, Headley PM, Paton JFR. Investigation of systemic bupivacaine toxicity using the in situ perfused working heart-brainstem preparation of the rat. Anesthesiology. 2002, 97 (6) 1550-1556.
15. Berde CB, Strichartz GR. Local Anesthetics. In Anesthesia, 5th Ed.; Miller, RD., Ed.; Churchill Livingstone: Philadelphia, 2000; 491-521.
16. Coyle DE, Porembka DT, Sehlhorst CS, Wan L, Behbehani MM. Echocardiographic evaluation of bupivacaine cardiotoxicity. Anesth. Analg. 1994,79 (2), 335-339.
17. Knudsen K, Suurkula MB, Blomberg S, Sjovall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine,bupivacaine and placebo in volunteers. Br. J. Anaesth. 1997, 78 (5), 507-514.
18. Nystrom EU, Heavner JE, Buffington CW. Blood Pressure Is Maintained Despite Profound Myocardial Depression During Acute Bupivacaine Overdose in Pigs. Anesth. Analg. 1999, 85 (8),1143-1148.
19. Phillips N, Priestly M, Denniss AR, Uther JB Brugada-type Electrocardiographic pattern induced by epidural bupivacaine. Anesth. Analg. 2003, 97 (1), 264-267.